Exempt Chemical Preparations Under the Controlled Substances Act
DEA published a list of approved/denied exempt chemical preparation applications received between July 1, 2025, and March 31, 2026. No new requirements or deadlines for existing operations.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 30, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Manufacturers and distributors that submitted exempt chemical preparation applications to DEA during the specified period. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified; action should be taken promptly upon publication.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA has accepted for filing and approved or denied applications for exempt chemical preparations received between July 1, 2025, and March 31, 2026.
Who it affects
Manufacturers and distributors that submitted exempt chemical preparation applications to DEA during the specified period.
What you must do
Review the published list to confirm the status of your application(s). If denied, determine next steps for compliance or reapplication.
Deadline
Not specified; action should be taken promptly upon publication.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
- Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
- Designation of P2P Methyl Glycidic Acid as a List I Chemical
- Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
- Revision of Applications for Manufacturing and Procurement Quotas